1Muellerleile K, Barmeyer A, Groth M, et al. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging[ J ]. Minerva Cardioangiol. 2008,56 ( 2 ) :237 - 249.
2Wita K, Filipecki A, Drzewiecka-Gerber A, et al. The use of myocardial contrast echocardiography in the assessment of left ventricular function recovery after primary percutaneous coronary intervention in the setting of acute myocardial infarction [ J ]. Kardiol Pol, 2006,64 ( 7 ) : 713 -721.
3Rambaldi R, Poldermans D, Bax JJ, et al. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction. Am J Cardiol, 1999, 84:130-134.
4Vanoverschelde J-LJ, Melin JA. Metabolic imaging and contractile reserve for assessment of myocardial viability: friends or foes? J Nucl Cardial, 1999,6:458-461.
5Canna GL, Rahirntoola SH, Visioli O, et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J, 2000,21:1358-1367.
6Vanoverschelde J-LJ, D′Hondt A-M, Marwick T, et al. Head-to-head comparison of exercise-redistrebution-reinjection Thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol, 1996,28:432-442.
7Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with ^201Tl single-photon emission computed tomography. Circulation, 1995,91:2748-2752.
8Lin LC, Ho YL, Wu CC, et al. Comparison of simultaneous dobutamine echocardiography and thallium-201 stress-reinjection single-photon emission computed tomography in predicting improvement of chronic myocardial dysfunction after revascularization. Am J Cardial, 2000,86:293-298.
9Cornel JH, Bax JJ, Elhendy A, et al. Agreement and disagreement between "metablic viability" and "contractile reserve" in akinetic myocardium. J Nucl Cardiol, 1999,6:383-388.
10Baer FM, Voth E, Deutsch HJ, et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization, J Am Coll Cardiol, 1996,28:60-69.
4Braunwald E, Kloner RA. The stunned myocardium : pro-longed,postischemic ventricular dysfunction. Circulation, 1982 , 66 ( 6 ):1146-1149.
5Rahimtoola SH. A perspective on the three large multicenterran-domized clinical trials of coronary bypass surgery for chronicstable angina. Circulation, 1985 ,72( supply) : 123-125.
6Schinkel AFL,Poldermans D,Elhendy A,et al. Prognostic role ofdobutamine stress echocardiography in myocardial viability. CurrOpin Cardiol, 2006,21(5) : 443-449.
7Mondillo S ,Galderisi M, Mele D,et al. Speckle-tracking echocardiography :a new technique for assessing myocardial function. J UltrasoundMed,2011,30(1 ):71-83.
8Cerqueira MD, Weissman NJ,Dilsizian V,et al. Standardizedmyocardial segmentation and nomenclature for tomographic imagingof the heart : a statement for healthcare professionals from the CardiacImaging Committee of the Council on Clinical Cardiology of theAmerican Heart Association. Circulation,2002,105(4) :539-542.
9Binoy K,Farooq A. Echocardiographic assessment of viable myocardium.Prog Cardiovasc Dis,2001 ,43(4) :351-361.
10Bansal M, Jeffriess L, Leano R, et al. Assessment of myocardialviability at dobutamine echocardiography by deformation analysisusing tissue velocity and speckle-tracking. J Am Coll Cardiol,2010,3(2) :121-131.
